Thus, we postulated that the differential abundance of CK1α in distinct tissues is the consequence of its Wnt-dependent regulation, and that the resultant lower levels of CK1α in CRC sensitize tumor tissue to CK1α agonists (7). The gene discussed is CSNK1A1; the disease is colorectal carcinoma.